Kevin Thomas
I'm a co-founder of Gosset, an AI-native pharmaceutical intelligence platform. We organize the world's drug development data into a knowledge graph and use AI to help pharmaceutical companies and life science investors forecast trial outcomes, value drug assets, and conduct commercial research. Prior to Gosset, I co-founded Saliency, a company that developed AI-enabled medical imaging biomarkers. Saliency was acquired by Clario in 2020 and I subsequently served as Clario's Director of AI.
Before that, I was a researcher within the Stanford University Neuromuscular Biomechanics Lab where I leveraged AI to further the understanding of musculoskeletal diseases. I have worked with some of the top organizations in health and human performance (Adidas, Philadelphia Phillies, EXOS) to advance their machine learning and biomechanics capabilities. I have a PhD in biomedical data science from Stanford. I also completed the first two years of medical school there as an MD/PhD dual degree student before leaving to start Gosset. Before attending graduate school, I conducted research in Canada as a Fulbright Scholar.
Select Work